Cybin
Cybin is a clinical stage pharmaceutical company that is working to bring psychedelic-based therapeutics to market to address mental health issues such as major depressive disorder and anxiety disorder in patients. Cybin's research focuses on psilocybin, a naturally occurring psychedelic compound found in certain mushrooms. In 2022, it conducted its first human trial. There are currently three active drug programs underway.